Here today, gone tomorrow: Outcomes of residual leak following secundum atrial septal defect closure with the GORE CARDIOFORM Septal Occluder
- PMID: 31876383
- DOI: 10.1002/ccd.28666
Here today, gone tomorrow: Outcomes of residual leak following secundum atrial septal defect closure with the GORE CARDIOFORM Septal Occluder
Abstract
Objective: To assess the outcomes and potential predictors of residual leak after implantation of the GORE CARDIOFORM Septal Occluder (GSO) in secundum atrial septal defects (ASDs).
Background: The non-self-centering design of the GSO could lead to residual leak at the edge of the device. Outcomes of residual leak are poorly understood.
Methods: Retrospective, multicenter review of patients treated with the GSO for the pivotal and continued access study. Procedural, echocardiographic, and follow up data were reviewed. Multivariate analysis was performed to determine predictors of leak at implant and outcomes of these leaks.
Results: There were 370 total ASD device closures with the GSO, 65 (17.56%) of which were found to have residual leak at implantation. Patients with residual leak had larger defects (10.33 ± 3.05 mm vs. 9.13 ± 2.89 mm, p = .006) and smaller aortic rims (4.87 ± 3.33 mm vs. 6.17 ± 3.78 mm, p = .019), as compared to those without leak. Larger devices were implanted (p = .008) and more devices per case (p = .007) were utilized in the residual leak cohort as compared to those without leak. Overall, among patients with residual leak, there was a significant decrease in leak size over 1 year, from 1.55 ± 0.75 mm to 0.25 ± 0.74 mm (p < .001), with the majority (87.6%) disappearing by 12-month follow-up.
Conclusions: Residual leak at implantation can be seen after ASD device closure with the GSO, more commonly in larger defects with smaller retroaortic rims. The vast majority of these leaks completely resolve by 1 year follow up.
Keywords: atrial septal defect; congenital heart disease; device closure; leak; transcatheter intervention.
© 2019 Wiley Periodicals, Inc.
Comment in
-
Not to worry (most of the time).Catheter Cardiovasc Interv. 2020 Apr 1;95(5):937-938. doi: 10.1002/ccd.28877. Catheter Cardiovasc Interv. 2020. PMID: 32294331
References
REFERENCES
-
- Abu-Tair T, Wiethoff CM, Kehr J, Kuroczynski W, Kampmann C. Transcatheter closure of atrial septal defects using the GORE((R)) Septal Occluder in children less than 10 kg of body weight. Pediatr Cardiol. 2016;37:778-783.
-
- Grohmann J, Hohn R, Fleck T, Schmoor C, Stiller B. Transcatheter closure of atrial septal defects in children and adolescents: single-center experience with the GORE(R) Septal Occluder. Catheter Cardiovasc Interv. 2014;84:E51-E57.
-
- Nyboe C, Hjortdal VE, Nielsen-Kudsk JE. First experiences with the GORE((R)) Septal Occluder in children and adults with atrial septal defects. Catheter Cardiovasc Interv. 2013;82:929-934.
-
- Smith B, Thomson J, Crossland D, Spence MS, Morgan GJ. UKmulticenter experience using the GORE Septal Occluder (GSO(TM)) for atrial septal defect closure in children and adults. Catheter Cardiovasc Interv. 2014;83:581-586.
-
- Grohmann J, Wildberg C, Zartner P, et al. Multicenter midterm follow-up results using the GORE Septal Occluder for atrial septal defect closure in pediatric patients. Catheter Cardiovasc Interv. 2017;89:E226-E232.
Publication types
MeSH terms
Supplementary concepts
LinkOut - more resources
Full Text Sources